ESR1 and breast cancer: The BRCA1f5–13 mouse had intermediate to high grade tumors with high mitotic count, expansive growth, moderate to high nuclear grade also displayed ER-negative immunohistochemistry staining with pushing borders, and increased expression of basal epithelial markers, similar to human basal-like breast cancer (94).